CoChat

Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

BACKGROUND: We previously showed that stool samples of pre-adolescent and adolescent US children diagnosed with diarrhea-predominant IBS (IBS-D) had different compositions of microbiota and metabolites compared to healthy age-matched controls. Here we explored whether observed fecal microbiota and metabolite differences between these two adolescent populations can be used to discriminate between IBS and health. FINDINGS: We constructed individual microbiota- and metabolite-based sample classification models based on the partial least squares multivariate analysis and then applied a Bayesian approach to integrate individual models into a single classifier. The resulting combined classification achieved 84 % accuracy of correct sample group assignment and 86 % prediction for IBS-D in cross-validation tests. The performance of the cumulative classification model was further validated by the de novo analysis of stool samples from a small independent IBS-D cohort. CONCLUSION: High-throughput microbial and metabolite profiling of subject stool samples can be used to facilitate IBS diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40168-015-0139-9

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic overview of the classification model generation. Pink and green points represent individual kIBS and kHLT samples, respectively, distributed in the simulated T-vs-Torthogonal PLS ordination space. Blue point represents an unknown sample that is classified by the PLS-DA models. M and C denote overall microbiota- and metabolite-based classification models, respectively; G is the group identifier; b 0…n are numerical parameters and m 1…n and c 1…p are values of specific microbes and metabolites, respectively. See statistical data analyses section for the definitions of Bayesian model terms and parameters
Fig. 1 Schematic overview of the classification model generation. Pink and green points represent individual kIBS and kHLT samples, respectively, distributed in the simulated T-vs-Torthogonal PLS ordination space. Blue point represents an unknown sample that is classified by the PLS-DA models. M and C denote overall microbiota- and metabolite-based classification models, respectively; G is the group identifier; b 0…n are numerical parameters and m 1…n and c 1…p are values of specific microbes and metabolites, respectively. See statistical data analyses section for the definitions of Bayesian model terms and parametersCC BY · PubMed Central
Fig. 2 Improvement of sample classification based on the integration of microbiota- and metabolite-based PLS-DA models. a Sample classifications are shown as provided by the microbial genus abundance-based PLS-DA model (top row), metabolite-based PLS-DA model (middle row), and combined Bayesian model (bottom row). Each column represents a unique sample from IBS and healthy sets as shown. Each square is colored according to the group assignment confidence based on the gradient as shown in the legend. Average assignment accuracy and confidence for each model are indicated at the right of the figure. b Application of the Bayesian integration model to a set of four new IBS-D samples. c Density distribution plots of PDI values for IBS-D and healthy adolescent samples. Top three discriminating genera and metabolites were used to compute PDI values. The X axis shows the range of PDI values; the Y axis represents the density (frequency) of PDI values at each position along the X axis. PDI values for individual kIBS and kHLT samples are shown on the plots as discrete points. Blue points represent new IBS-D samples. d Receiver operating characteristic analysis of PLS-DA models (left panel) and patient discrimination indices (right panel). AUC area under the curve (represents the discrimination ability of each model; higher value equals better discrimination), G genus, M metabolite
Fig. 2 Improvement of sample classification based on the integration of microbiota- and metabolite-based PLS-DA models. a Sample classifications are shown as provided by the microbial genus abundance-based PLS-DA model (top row), metabolite-based PLS-DA model (middle row), and combined Bayesian model (bottom row). Each column represents a unique sample from IBS and healthy sets as shown. Each square is colored according to the group assignment confidence based on the gradient as shown in the legend. Average assignment accuracy and confidence for each model are indicated at the right of the figure. b Application of the Bayesian integration model to a set of four new IBS-D samples. c Density distribution plots of PDI values for IBS-D and healthy adolescent samples. Top three discriminating genera and metabolites were used to compute PDI values. The X axis shows the range of PDI values; the Y axis represents the density (frequency) of PDI values at each position along the X axis. PDI values for individual kIBS and kHLT samples are shown on the plots as discrete points. Blue points represent new IBS-D samples. d Receiver operating characteristic analysis of PLS-DA models (left panel) and patient discrimination indices (right panel). AUC area under the curve (represents the discrimination ability of each model; higher value equals better discrimination), G genus, M metaboliteCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 26

Metadata

Authors
Shankar, V., Reo, N. V., & Paliy, O.
Affiliations
Wright State University (US)
Corresponding author
Paliy, Oleg
Venue
Microbiome
Published
2015-12
Volume
3
Issue
1
Pages
73-73
ISSN
2049-2618 (ISSN-L)
OpenAlex
W2192147642
Cited by
26
References
19
Citations by year
2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 1
FWCI
0.72
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbiome (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (AT003423, HD065575)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
Keywords
pediatric irritable bowel syndrome, diarrhea-predominant irritable bowel syndrome, fecal microbiota, fecal metabolites, Bayesian classifier, sample classification, IBS diagnosis, adolescents, PLS-DA
MeSH terms
Adolescent, Bayes Theorem, Child, DNA, Bacterial, Feces, Female, Humans, Male, Irritable Bowel Syndrome, Metabolomics, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. https://app.cochat.ai/papers/10.1186/s40168-015-0139-9
The paper
Shankar, V., Reo, N. V., & Paliy, O. (2015). Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. Microbiome. https://doi.org/10.1186/s40168-015-0139-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.